Literature DB >> 10561289

Doxorubicin cardiotoxicity: growing importance.

B Orhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10561289

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  P-glycoprotein induction and tumor cell-kill dynamics in response to differential doxorubicin dosing strategies: a theoretical pharmacodynamic model.

Authors:  Kenneth T Luu; James A Uchizono
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

2.  Doxorubicin-conjugated PLA-PEG-Folate based polymeric micelle for tumor-targeted delivery: synthesis and in vitro evaluation.

Authors:  Zahra Hami; Mohsen Amini; Mahmoud Ghazi-Khansari; Seyed Mehdi Rezayat; Kambiz Gilani
Journal:  Daru       Date:  2014-03-06       Impact factor: 3.117

3.  Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis.

Authors:  Joydeep Das; Yun-Jung Choi; Jae Woong Han; Abu Musa Md Talimur Reza; Jin-Hoi Kim
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells.

Authors:  Xianpu Zhang; Jiaojiao Li; Yongbo Cheng; Jianguang Yi; Xin Liu; Wei Cheng
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952

5.  Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.

Authors:  Marzena Szwed; Audrey Laroche-Clary; Jacques Robert; Zofia Jozwiak
Journal:  Cell Oncol (Dordr)       Date:  2015-11-26       Impact factor: 6.730
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.